Autologous fat transfer, also known as “lipofilling”, is a minimally invasive procedure in which the plastic surgeon uses the patient's own fat obtained by liposuction to perform breast reconstruction.
Autologous fat transfer, also known as “lipofilling”, is a minimally invasive procedure in which the plastic surgeon uses the patient's own fat obtained by liposuction to perform breast reconstruction. For more than a decade, experts have questioned the oncological safety of this technique when applied to the former breast cancer patient, because autologous fat transfer stimulates the formation of blood vessels and tissue regeneration; however, a recent BJS (British Journal of Surgery) meta-analysis of published studies found that the technique does not result in an increased rate of cancer recurrence.
The findings indicate that autologous fat transfer can be performed safely in breast reconstruction after breast cancer.
"Lipofilling need not be feared of causing cancer relapse in the former breast cancer patient,” said lead author Dr. Todor Krastev of Maastricht University Medical Centre in the Netherlands.
Additional Information
Link to Study: https://onlinelibrary.wiley.com/doi/abs/10.1002/bjs.10887
About Journal
With an impact factor of 5.899, BJS is the premier surgical journal in Europe and one of the top six surgical periodicals in the world. Its international readership is reflected in the prestigious international Editorial Board, supported by a panel of over 1200 reviewers worldwide.
BJS features the very best in clinical and laboratory-based research on all aspects of general surgery and related topics. Developing areas such as minimally invasive therapy and interventional radiology are strongly represented.
The inclusion of Leading articles, Reviews and Original Articles means that the BJS offers an appropriate format for any length or type of submission. In addition there are abstracts from key meetings and correspondence.
BJS will be of interest not only to general surgeons, but also to specialty surgeons and those working in related fields.
Josh Glickman
+1 201-748-6572
sciencenewsroom@wiley.com